






















Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 19, 2017
Draft Genome Sequences of Pseudomonas aeruginosa B3 Strains Isolated from a
Cystic Fibrosis Patient Undergoing Antibiotic Chemotherapy
Marvig, Rasmus Lykke; Jochumsen, Nicholas; Johansen, Helle Krogh; Høiby, Niels; Molin, Søren;
Sommer, Morten Otto Alexander; Jelsbak, Lars; Folkesson, Anders
Published in:
Genome Announcements





Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Marvig, R. L., Jochumsen, N., Johansen, H. K., Høiby, N., Molin, S., Sommer, M., ... Folkesson, A. (2013). Draft
Genome Sequences of Pseudomonas aeruginosa B3 Strains Isolated from a Cystic Fibrosis Patient Undergoing
Antibiotic Chemotherapy. Genome Announcements, 1(5), [e00804-13]. DOI: 10.1128/genomeA.00804-13
Draft Genome Sequences of Pseudomonas aeruginosa B3 Strains
Isolated from a Cystic Fibrosis Patient Undergoing Antibiotic
Chemotherapy
Rasmus Lykke Marvig,a Nicholas Jochumsen,a Helle Krogh Johansen,b Niels Høiby,b Søren Molin,a Morten O. Sommer,a Lars Jelsbak,a
Anders Folkessona
Department of Systems Biology, Technical University of Denmark, Lyngby, Denmarka; Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmarkb
Pseudomonas aeruginosa frequently establishes chronic infections in the airways of patients suffering from cystic fibrosis (CF).
Here, we report the draft genome sequences of four P. aeruginosa B3 strains isolated from a chronically infected CF patient un-
dergoing antibiotic chemotherapy.
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Cystic fibrosis (CF) patients are subjected to intensive antibiotictherapy, and it is evident that this crucially affects the process
of bacterial adaptation to the CF lung environment (1, 2). To
further investigate the effects of antimicrobial chemotherapy on
the adaptation of Pseudomonas aeruginosa to the CF lung, we se-
quenced the genomes of four strains of the P. aeruginosa B3 clone
type isolated from consecutive sputum samples from a patient
with long-term chronic P. aeruginosa infection undergoing
3 months of combination chemotherapy with oral ciprofloxacin
and inhaled colistin due to recurrent isolation of P. aeruginosa.
The sputum samples were collected and the strains were isolated
as part of a longitudinal study where the first and subsequent
samples were stored from the beginning of 2005 until July 2009
(1). The first sample was collected before chemotherapy was ini-
tiated and is represented by P. aeruginosa B3-1811, a mucoid iso-
late that was determined at the clinic to be colistin and ciprofloxa-
cin sensitive. A sputum sample collected 2 months after the
initiation of therapy contained P. aeruginosa with two different
bacterial colony morphologies: a mucoid and colistin-sensitive
strain (P. aeruginosa B3-208) and a nonmucoid and colistin-
resistant strain (P. aeruginosa B3-20M). The last strain (P. aerugi-
nosa B3-CFI), also colistin resistant, was isolated from a sputum
sample obtained at the end of the 3-month treatment regime.
Genomic DNA from the B3-1811, B3-208, B3-20M, and B3-CFI
strains was prepared and sequenced as described previously (3) to
generate 3,077,857, 2,445,795, 3,026,144, and 3,881,715 75-bp
reads, respectively.
Using Velvet version 1.0.16, the reads were assembled into the
draft genomes of strain B3-1811, with 6,657,892 bp, 285 contigs,
and an N50 of 82,268 bp; strain B3-208, with 6,701,506 bp, 344
contigs, and an N50 of 66,611 bp; strain B3-20M, with
6,704,349 bp, 278 contigs, and an N50 of 77,595 bp; and strain
B3-CFI, with 6,727,794 bp, 252 contigs, and an N50 of 87,472 bp.
The optimal assembly settings were estimated using Velvet-
Optimiser (the Victorian Bioinformatics Consortium [VBC],
Monash University; see http://www.vicbioinformatics.com
/software.velvetoptimiser.shtml), with only contigs of 500 bp
retained, and the assembly was assisted by initial mapping of the
reads against the reference genome sequences of P. aeruginosa
PAO1 (4) using the Velvet Columbus module.
A comparison of the genomes usingMUMmer3 (5) revealed
the four isolates to be closely related, sharing at least 99.6% of
their genomic contents. The sequences of the four strains re-
ported here will help to elucidate the genetic diversity that
exists within clonal populations of P. aeruginosa sampled from
a single CF patient and how the genetic composition can
change quickly due to new selection pressures, such as antibi-
otic therapy.
Nucleotide sequence accession numbers. These genome se-
quences have been deposited in EMBL under the following acces-
sion no. (BioProject no.): CBMP010000001 to CBMP010000341
(PRJEB4309) for strain B3-1811, CBMT010000001 to
CBMT010000418 (PRJEB4310) for strain B3-208, CBMU010000001
to CBMU010000338 (PRJEB4311) for strain B3-20M, and
CBMS010000001 to CBMS010000314 (PRJEB4312) for strain
B3-CFI.
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